Formularies: the role of pharmacy-and-therapeutics (P&T) committees
- PMID: 8519049
Formularies: the role of pharmacy-and-therapeutics (P&T) committees
Abstract
Pharmacy-and-therapeutics (P&T) committees have been established by most hospitals and serve as the primary formal communications link between pharmacy and the medical staff. The P&T committee is responsible for all matters related to the use of medications in the institution, including the development and maintenance of the formulary (the continually revised compilation of drug products available to the medical staff). The basic objectives of a P&T committee are to specify drugs of choice and alternatives, based on safety and efficacy; to minimize therapeutic redundancies; and to maximize cost-effectiveness. Procedures necessary to strengthen the role of P&T committees and improve their decision-making processes are discussed. The increasing concern with controlling health care costs will support the continued expansion of P&T committees, formularies, and the formulary system.
Similar articles
-
Formulary decision making: identifying factors that influence P&T committee drug evaluations.Hosp Formul. 1988 Feb;23(2):174-8. Hosp Formul. 1988. PMID: 10286022
-
P & T Committee formulary requests: criteria for admission.Hosp Formul. 1984 Oct;19(10):975-7, 980. Hosp Formul. 1984. PMID: 10268315
-
A survey of selective administration procedures in formulary maintenance.Hosp Pharm. 1981 Jul;15(7):371-4, 378-80. Hosp Pharm. 1981. PMID: 10252001
-
Controlling financial variables--changing prescribing patterns.Am J Hosp Pharm. 1984 Mar;41(3):503-15. Am J Hosp Pharm. 1984. PMID: 6367444 Review.
-
The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.Drug Saf. 1998 Mar;18(3):153-9. doi: 10.2165/00002018-199818030-00001. Drug Saf. 1998. PMID: 9530535 Review.
Cited by
-
Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study.JAC Antimicrob Resist. 2020 May 10;2(2):dlaa023. doi: 10.1093/jacamr/dlaa023. eCollection 2020 Jun. JAC Antimicrob Resist. 2020. PMID: 34222987 Free PMC article.
-
Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.Pharmacoeconomics. 1996 May;9(5):430-42. doi: 10.2165/00019053-199609050-00006. Pharmacoeconomics. 1996. PMID: 10160255 Review.
-
[Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].Med Klin (Munich). 1998 Feb 15;93(2):119-24. doi: 10.1007/BF03043288. Med Klin (Munich). 1998. PMID: 9545712 German.
-
Indicators for drug and therapeutics committees.Br J Clin Pharmacol. 1998 Apr;45(4):393-8. doi: 10.1046/j.1365-2125.1998.t01-1-00699.x. Br J Clin Pharmacol. 1998. PMID: 9578188 Free PMC article.
-
Rule-based standardised switching of drugs at the interface between primary and tertiary care.Eur J Clin Pharmacol. 2008 Mar;64(3):319-27. doi: 10.1007/s00228-007-0402-5. Epub 2007 Nov 25. Eur J Clin Pharmacol. 2008. PMID: 18038228